Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Silver complexes with sulfathiazole and sulfamethoxazole: Synthesis, spectroscopic characterization, crystal structure and antibacterial assays

Full text
Author(s):
Bormio Nunes, Julia Helena [1] ; Ferraz de Paiva, Raphael Enoque [1] ; Cuin, Alexandre [2] ; Lustri, Wilton Rogerio [3] ; Corbi, Pedro Paulo [1]
Total Authors: 5
Affiliation:
[1] Univ Campinas UNICAMP, Bioinorgan & Med Chem Res Lab, BR-13083970 Campinas, SP - Brazil
[2] Univ Fed Juiz de Fora, Bioinorgan Chem Res Lab, BR-36036330 Juiz De Fora, MG - Brazil
[3] Centro Univ Araraquara, Biol & Hlth Sci Dept, BR-14801320 Araraquara, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: Polyhedron; v. 85, p. 437-444, JAN 8 2015.
Web of Science Citations: 22
Abstract

The present work describes the synthesis and spectroscopic characterization of two silver(I) complexes with the sulfonamides sulfathiazole (AgC9H8N3O2S2, Ag-SFF) and sulfamethoxazole (AgC10H10N3O3S, Ag-SFM). Elemental analyses indicate a 1:1 metal/ligand composition for both complexes. Spectroscopic techniques such as H-1, N-15 NMR and IR evidence the coordination of both ligands to silver through the nitrogen atom of the sulfonamide group, and also indicate the participation of the 5-membered N-heterocyclic ring in the coordination. The Ag-SFT crystal structure was solved by X-ray powder diffraction and indicates the formation of a dimeric structure with silver bridging between two ligand molecules. Biological studies showed the antibacterial activity of Ag-SFT and Ag-SFM complexes against Gram-positive and Gram-negative bacterial strains, with MIC values ranging from 3.45 to 6.90 mmol L-1 for the sulfathiazole complex and 1.74 to 13.9 mmol L-1 for the sulfamethoxazole complex. The complexes have shown to be more active against Gram-negative bacterial strains. (C) 2014 Elsevier Ltd. All rights reserved. (AU)

FAPESP's process: 12/08230-2 - Synthesis, characterization and pharmacological studies of Ag(I), Au(I), Pt(II) and Pd(II) complexes with bioactive ligands
Grantee:Pedro Paulo Corbi
Support Opportunities: Regular Research Grants